aTYR PHARMA INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
aTYR PHARMA INC quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • aTYR PHARMA INC Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $727K, a 10.5% increase year-over-year.
  • aTYR PHARMA INC Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.79M, a 11.7% increase year-over-year.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2023 was $2.6M, a 20.7% increase from 2022.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2022 was $2.15M, a 33.5% increase from 2021.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2021 was $1.61M, a 10.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.79M $727K +$69K +10.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.72M $740K +$121K +19.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2.6M $659K +$54K +8.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $2.55M $664K +$49K +7.97% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.5M $658K +$141K +27.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.36M $619K +$202K +48.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $2.15M $605K +$191K +46.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.96M $615K +$173K +39.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.79M $517K +$119K +29.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.67M $417K +$57K +15.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.61M $414K +$74K +21.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $1.54M $442K +$118K +36.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.42M $398K +$20K +5.29% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.4M $360K -$63K -14.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.47M $340K -$85K -20% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 $1.55M $324K +$46K +16.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.5M $378K -$131K -25.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.64M $423K -$148K -25.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $1.78M $425K -$177K -29.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 $1.96M $278K -$412K -59.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $2.37M $509K -$702K -58% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.07M $571K -$357K -38.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $3.43M $602K -$2.53M -80.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-24
Q3 2018 $5.96M $690K -$499K -42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $6.46M $1.21M +$28K +2.37% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $6.44M $928K -$349K -27.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $6.78M $3.14M +$1.98M +172% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 $4.8M $1.19M -$35K -2.86% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $4.84M $1.18M -$190K -13.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $5.03M $1.28M -$3K -0.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $5.03M $1.15M -$1.24M -51.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-26
Q3 2016 $6.26M $1.22M +$174K +16.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $6.09M $1.37M +$557K +68.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $5.53M $1.28M +$677K +112% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $4.86M $2.39M +$1.38M +137% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-20
Q3 2015 $3.48M $1.05M +$576K +122% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.9M $816K +$651K +395% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.25M $603K +$457K +313% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $1.79M $1.01M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $474K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $165K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $146K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.